Workflow
GE HealthCare Technologies (GEHC)
icon
Search documents
GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers
Businesswire· 2024-02-08 15:00
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MedQuest Associates (MedQuest), a leading owner, operator, and manager of outpatient diagnostic imaging facilities, today announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site o ...
S&P 500 Gains and Losses Today: GE HealthCare Shares Soar After Strong Earnings
Investopedia· 2024-02-06 22:10
Key TakeawaysThe S&P 500 gained 0.2% on Tuesday, Feb. 6, 2024, as Federal Reserve officials struck a tone of cautious optimism and more companies released quarterly results.GE HealthCare shares soared as growth in imaging and patient care solutions helped drive strong earnings.Shares of FMC Corp. tumbled after the agriculture firm provided lackluster guidance, reflecting the impact of low sales volume and destocking issues.Major U.S. stock indexes posted moderate gains as more companies reported earnings re ...
GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve
Zacks Investment Research· 2024-02-06 19:31
GE HealthCare (GEHC) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $1.18, which beat the Zacks Consensus Estimate of $1.07 by 10.3%. The bottom line, however, declined 9.9% year over year.GAAP EPS in the quarter was 88 cents, down 27.3% from the year-ago quarter’s level.Revenue DetailsThis currently Zacks Rank #3 (Hold) company reported revenues of $5.2 billion, up 5% from the prior-year quarter’s recorded number, reportedly as well as organically. The growth was driven by an improvement ...
GE HealthCare Technologies (GEHC) - 2023 Q4 - Earnings Call Presentation
2024-02-06 17:09
Organic Revenue Growth*(1) 8% Approximately 4% Free Cash Flow* $1.7 billion ~$1.8 billion | --- | --- | --- | |-----------------------|-------|----------------------------------| | Adjusted EBIT Margin* | 15.1% | 15.6% - 15.9% 50 - 80 bps growth | | Adjusted ETR* 23.7% | | 23% - 25% | | Adjusted EPS* | $3.93 | $4.20 - $4.35 7% - 11% growth | © 2024 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. 13 Investing in Digital for Future Growth Imaging Ultrasound Imaging A ...
GE HealthCare Technologies (GEHC) - 2023 Q4 - Earnings Call Transcript
2024-02-06 17:09
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2023 Earnings Conference Call February 6, 2024 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Graham Doyle - UBS Anthony Petrone - Mizuho Patrick Wood - ...
GE HealthCare Technologies stock surges on 4Q earnings beat
Proactive Investors· 2024-02-06 16:28
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
GE HealthCare (GEHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research· 2024-02-06 15:45
GE HealthCare Technologies (GEHC) reported $5.21 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 5.4%. EPS of $1.18 for the same period compares to $1.31 a year ago.The reported revenue represents a surprise of +2.21% over the Zacks Consensus Estimate of $5.09 billion. With the consensus EPS estimate being $1.07, the EPS surprise was +10.28%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Surpass Estimates
Zacks Investment Research· 2024-02-06 13:46
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.28%. A quarter ago, it was expected that this medical technology company would post earnings of $0.89 per share when it actually produced earnings of $0.99, delivering a surprise of 11.24%.Over the la ...
GE Healthcare's Q4 profit and revenue top estimates, offsetting soft EPS guidance
Market Watch· 2024-02-06 11:31
GE HealthCare Technologies Inc.’s stock GEHC, -0.68% rose 0.9% early Tuesday, after the company posted better-than-expected profit and revenue for the fourth quarter, offsetting soft guidance for 2024. GE HealthCare, which was spun out of General Electric Co. in January of 2023 and houses its medical device business, posted net income of $403 million, or 88 cents a share, for the quarter, down from $554 million, or $1.21 a share, in the year-earlier period. Adjusted per-share earnings came to $1.18, ahead ...
GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
Businesswire· 2024-02-06 11:20
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the fourth quarter ended December 31, 2023. GE HealthCare President and CEO Peter Arduini said, “After our first year as a publicly traded company, I’m pleased to announce robust fourth quarter and full year results. This strong financial performance is a testament to our dedicated team and successful execution of our precision care strategy. We’ve made significant strides ...